Design, Synthesis, and Biological Evaluation of Potent FLT3 Inhibitor for Acute Myeloid Leukemia (AML) Treatment

Documenti analoghi

• Design, Synthesis, and Biological Activities Evaluation of Type I FLT3 Inhibitors for the Treatment of Acute Myeloid Leukemia
  di: Jin Yang, et al.
  Pubblicazione: (2024)
• Diaryl Diimidazopyrimidine Derivatives as Potent Inhibitors of Influenza A Virus: Synthesis, Evaluation and Docking Studies
  di: Abburi Naga Pranathi, et al.
  Pubblicazione: (2025)
• Design, Green Synthesis, and Biological Evaluation of Novel Triaryl‐Tethered Acryloyl Derivatives as New Generation β‐Tubulin Inhibitors for Hepatocellular Carcinoma Treatment
  di: Aamal A. Al‐Mutairi, et al.
  Pubblicazione: (2026)
• Design, Synthesis, Biological Evaluation and Molecular Docking Study of New 1,3,4‐Thiadiazole‐Based Compounds as EGFR Inhibitors
  di: Marwa I. Serag, et al.
  Pubblicazione: (2024)
• Molecular Boomerangs Against Cancer: Design, Synthesis, Biological Evaluation, and In Silico Study of Novel Dual PARP‐1/EGFR Inhibitors
  di: Haytham O. Tawfik, et al.
  Pubblicazione: (2026)